Epilepsy is one of the most prevalent chronic neurological diseases and is characterized by unprovoked, irregular, and recurrent seizures. Epilepsy affects approximately 50 million people of all ages worldwide, and patients commonly suffer from stigma and discrimination [1]. Over the past decade, many government agencies and professional researchers have developed quality indicators for several fields to improve clinical care and to better meet patient expectations [2]. The American Academy of Neurology (AAN) has developed a set of standardized quality measures for epilepsy, including indicators focusing on the process of diagnosis and treatment for epilepsy, to monitor quality and drive improvements in epilepsy care [3–5].
19
MAR
MAR
0